Diagnos Inc.

Diagnos Inc.

October 08, 2009 10:52 ET

DIAGNOS Announces Memorandum of Understanding with Zeiss Canada Ltd

BROSSARD, QUEBEC--(Marketwire - Oct. 8, 2009) - DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in the use of artificial intelligence and advanced knowledge-extraction techniques, announces today that it has signed a Memorandum of Understanding, and associated Non-Disclosure Agreement with Zeiss Canada Ltd., the Canadian subsidiary of Carl Zeiss Meditec AG, Jena, Germany, a global leader in the ophthalmic diagnostic equipment market.

Under the terms of the MoU, DIAGNOS and Zeiss will work together to assure compatibility among DIAGNOS' Computer Assisted Retinal Analysis (CARA) technology and Zeiss' fundus camera and associated imaging software VisuPac, as well as jointly engage in pilot projects aimed at testing the integrated Zeiss / DIAGNOS offering in the marketplace.

"We are excited about our continuing relationship with Zeiss and their confidence in DIAGNOS, and look forward to working even more closely in the coming months" said Andre Larente, President of DIAGNOS.

"While the integration of CARA with Zeiss' VisuPac will allow Zeiss to offer an enhanced fundus image reading experience for their existing and new users, a strong relationship with a partner of Zeiss' global importance will allow us to move quickly to finalize our validation process and positions us well to commercialize our technology upon regulatory approval later this fall" said Peter Nowacki, DIAGNOS' General Manager.

About Zeiss

Founded in 1846, Carl Zeiss is today a global leader in the optical and opto-electronic industries, with approximately 13,000 employees and representatives across 100 countries in the Carl Zeiss Group of companies. Zeiss is a market leader in a majority of their markets, offering an extraordinary spectrum of leading-edge solutions and products. Zeiss' corporate slogan is "We make it visible" and their focus is to enable science and technology to go beyond what man can see.


Founded in 1998, DIAGNOS is a publicly traded Canadian corporation (TSX: ADK), with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision-making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including healthcare, natural resources, and entertainment.

For further information, please visit our website at www.diagnos.com or the SEDAR website at www.sedar.com.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release.

Contact Information

    Andre Larente - President
    & Investor relations
    1-877-678-8882 or 450-678-8882, ext. 224